Kiniksa Pharmaceuticals
KNSA
KNSA
56 hedge funds and large institutions have $295M invested in Kiniksa Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 31 increasing their positions, 5 reducing their positions, and 5 closing their positions.
Holders
56
Holders Change
+4
Holders Change %
+7.69%
% of All Funds
1.21%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
9
Increased
31
Reduced
5
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
ACH
1
ArrowMark Colorado Holdings
Denver,
Colorado
|
$29.1M |
2 |
VC
2
Vivo Capital
Palo Alto,
California
|
$15.2M |
3 |
HA
3
HHLR Advisors
Grand Cayman,
Cayman Islands
|
$33.2M |
4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$22.5M |
5 |
5
BlackRock
New York
|
$17.5M |